Cargando…
A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report
BACKGROUND: Clinical studies on the effects of thalidomide‐induced damage on thalidomide victims as they age have only recently started to be conducted, but no studies have examined socioeconomic differences in terms of healthcare and social status between thalidomiders and the age‐matched general p...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432171/ https://www.ncbi.nlm.nih.gov/pubmed/31339667 http://dx.doi.org/10.1002/bdr2.1558 |
_version_ | 1783571738520453120 |
---|---|
author | Hinoshita, Fumihiko Beppu, Hiroko Shioji, Shingo Fujitani, Junko Imai, Koubun Tajima, Tsuyoshi Tagami, Tetsuya Ohnishi, Shin |
author_facet | Hinoshita, Fumihiko Beppu, Hiroko Shioji, Shingo Fujitani, Junko Imai, Koubun Tajima, Tsuyoshi Tagami, Tetsuya Ohnishi, Shin |
author_sort | Hinoshita, Fumihiko |
collection | PubMed |
description | BACKGROUND: Clinical studies on the effects of thalidomide‐induced damage on thalidomide victims as they age have only recently started to be conducted, but no studies have examined socioeconomic differences in terms of healthcare and social status between thalidomiders and the age‐matched general population in Japan. Therefore, we carried out a nationwide survey focusing on the life situations of thalidomiders. METHOD: Questionnaires were sent to 274 thalidomiders in Japan. The questionnaire items basically matched those of the Comprehensive Survey of Living Conditions (CSLC) in the general population conducted by the Japanese Government. The results were compared with those of the CSLC for individuals aged 55–59 years, which was the cohort most similar in age to the average thalidomider living in Japan. RESULTS: More thalidomiders rated their health condition as relatively bad or bad compared with the general population (20.2% vs. 13.3%, respectively). A much higher percentage of thalidomiders reported having some health or physical problem caused by a disease or injury (68.8% vs. 32.6%, respectively), and thalidomiders reported visiting medical and healthcare‐related facilities more frequently. A higher proportion of thalidomiders (9.2%) were unemployed, and thalidomiders tended to feel higher levels of worry and stress, especially in terms of the future. CONCLUSIONS: The results of this nationwide survey of the life situations of thalidomiders in Japan clarified their health conditions and the related associations with socioeconomic status. These findings could be expected to help improve the provision of medical and healthcare, welfare measures, and financial support for thalidomiders in the near future. |
format | Online Article Text |
id | pubmed-7432171 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | John Wiley & Sons, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-74321712020-08-20 A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report Hinoshita, Fumihiko Beppu, Hiroko Shioji, Shingo Fujitani, Junko Imai, Koubun Tajima, Tsuyoshi Tagami, Tetsuya Ohnishi, Shin Birth Defects Res Research Articles BACKGROUND: Clinical studies on the effects of thalidomide‐induced damage on thalidomide victims as they age have only recently started to be conducted, but no studies have examined socioeconomic differences in terms of healthcare and social status between thalidomiders and the age‐matched general population in Japan. Therefore, we carried out a nationwide survey focusing on the life situations of thalidomiders. METHOD: Questionnaires were sent to 274 thalidomiders in Japan. The questionnaire items basically matched those of the Comprehensive Survey of Living Conditions (CSLC) in the general population conducted by the Japanese Government. The results were compared with those of the CSLC for individuals aged 55–59 years, which was the cohort most similar in age to the average thalidomider living in Japan. RESULTS: More thalidomiders rated their health condition as relatively bad or bad compared with the general population (20.2% vs. 13.3%, respectively). A much higher percentage of thalidomiders reported having some health or physical problem caused by a disease or injury (68.8% vs. 32.6%, respectively), and thalidomiders reported visiting medical and healthcare‐related facilities more frequently. A higher proportion of thalidomiders (9.2%) were unemployed, and thalidomiders tended to feel higher levels of worry and stress, especially in terms of the future. CONCLUSIONS: The results of this nationwide survey of the life situations of thalidomiders in Japan clarified their health conditions and the related associations with socioeconomic status. These findings could be expected to help improve the provision of medical and healthcare, welfare measures, and financial support for thalidomiders in the near future. John Wiley & Sons, Inc. 2019-07-24 2019-12-01 /pmc/articles/PMC7432171/ /pubmed/31339667 http://dx.doi.org/10.1002/bdr2.1558 Text en © 2019 The Authors. Birth Defects Research published by Wiley Periodicals, Inc. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
spellingShingle | Research Articles Hinoshita, Fumihiko Beppu, Hiroko Shioji, Shingo Fujitani, Junko Imai, Koubun Tajima, Tsuyoshi Tagami, Tetsuya Ohnishi, Shin A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report |
title | A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report |
title_full | A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report |
title_fullStr | A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report |
title_full_unstemmed | A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report |
title_short | A nationwide survey regarding the life situations of patients with thalidomide embryopathy in Japan, 2018: First report |
title_sort | nationwide survey regarding the life situations of patients with thalidomide embryopathy in japan, 2018: first report |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7432171/ https://www.ncbi.nlm.nih.gov/pubmed/31339667 http://dx.doi.org/10.1002/bdr2.1558 |
work_keys_str_mv | AT hinoshitafumihiko anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport AT beppuhiroko anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport AT shiojishingo anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport AT fujitanijunko anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport AT imaikoubun anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport AT tajimatsuyoshi anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport AT tagamitetsuya anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport AT ohnishishin anationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport AT hinoshitafumihiko nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport AT beppuhiroko nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport AT shiojishingo nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport AT fujitanijunko nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport AT imaikoubun nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport AT tajimatsuyoshi nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport AT tagamitetsuya nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport AT ohnishishin nationwidesurveyregardingthelifesituationsofpatientswiththalidomideembryopathyinjapan2018firstreport |